Full-Time

Sleep Technician

Updated on 8/23/2026

Main Line Health

Main Line Health

51-200 employees

Biomedical research division advancing cancer science

No salary listed

Paoli, PA, USA

In Person

Bachelor's, Certification

Category
Medical, Clinical & Veterinary (1)
Required Skills
ACLS
Basic Life Support (BLS)

Get referred to Main Line Health

See people who can refer or advise you

Requirements
  • A minimum of 2 years of experience in a full-service Sleep Disorders Center laboratory or equivalent experience is preferred.
  • A BA or BS from an accredited institution is preferred.
  • Specific training in polysomnographic technology, electroencephalography technology, or respiratory technology from an accredited institution is preferred.
  • Ability to read, write, speak, communicate, and understand English sufficiently to perform the duties of the job is required.
  • Basic Life Support or Advanced Cardiovascular Life Support certification is required.
  • One of the following American Academy of Sleep Medicine-endorsed registrations is required: American Board of Sleep Medicine Registered Sleep Technologist, Board of Registered Polysomnographic Technologists Registered Polysomnographic Technologist, or Pennsylvania-licensed Registered Respiratory Therapist with the National Board for Respiratory Care advanced Sleep Disorders Specialist credential.
  • Graduation from a CAHEEP-accredited school for Clinical Neurophysiology and/or obtaining a polysomnographer technician certificate is required.
  • The Registered Sleep Technologist and/or Registered Polysomnographic Technologist registration must be obtained within 10 months of hire.
Responsibilities
  • Conduct and/or analyze sleep recordings of patients of all ages except infancy.
  • Perform other related duties in the Sleep Disorders Center laboratories.
Desired Qualifications
  • A minimum of 2 years of experience in a full-service Sleep Disorders Center laboratory or equivalent experience.
  • A BA or BS from an accredited institution.
  • Specific training in polysomnographic technology, electroencephalography technology, or respiratory technology from an accredited institution.

Lankenau Institute for Medical Research (LIMR) is the research division of Main Line Health that conducts cancer and biomedical research and translates basic science into clinical applications. LIMR studies cell growth and cancer biology, develops discoveries in the lab, and collaborates to move findings into patient care within the health system. It differs from other research centers by its long history as one of the first U.S. cancer-focused institutes, its integration within a hospital-based health system, and its track record of translational research—turning lab findings into clinical therapies and practices. The institute aims to improve patient outcomes by turning basic science into usable medical treatments and interventions for cancer and related diseases.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Lancaster, Pennsylvania

Founded

1927

Get referred to Main Line Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Fiscal 2026 first-half operating profit reached $8.7 million, reversing prior-year loss.
  • Revenue rose 10.5% to $1.35 billion through December 31, 2025, on stronger patient volume.
  • PROPEL enrollment follows treatment of 37 patients, giving Main Line Health early clinical momentum.

What critics are saying

  • January 2025 layoffs cut nearly 200 administrative jobs, signaling ongoing reimbursement pressure and cost discipline.
  • March 2026 malpractice fallout tied Main Line Health to a contaminated-biopsy hysterectomy lawsuit settlement.
  • Additional $21 million malpractice accruals crushed third-quarter fiscal 2026 results, exposing recurring liability risk.

What makes Main Line Health unique

  • LIMR anchors Main Line Health's translational research, running trials like PROPEL on March 25, 2026.
  • Main Line Health was Pennsylvania's first provider of Aliya PEF soft-tissue ablation, March 25, 2026.
  • The system combines four hospitals with LIMR scientists, accelerating bedside-to-bench cancer and cardiovascular work.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Pension

403(b) Retirement Plan

Unlimited Paid Time Off

Tuition Reimbursement

Wellness Program

Family Planning Benefits

Growth & Insights and Company News

Headcount

6 month growth

3%

1 year growth

3%

2 year growth

3%
PR Newswire
Nov 22nd, 2024
Independence Blue Cross Launches Epic Payer Platform To Transform Care Coordination And Boost Member Health Outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform with health systems and providers in its network to streamline data exchange, close gaps in care, and improve health outcomes for members. Epic Payer Platform is part of Epic, a global healthcare technology company. The platform helps facilitate data exchange and workflow processes for providers and health plans, giving them the insights they need to make care decisions while also saving them time. "We're excited about the implementation of Epic Payer Platform with Drexel Medicine, Jefferson Health, Main Line Health, and Penn Medicine being the first to join us in this transformation. We look forward to more of our health care partners signing on as well," said Michael Vennera, executive vice president and chief strategy, technology, and operations officer at Independence Blue Cross

Managed Healthcare Executive
Feb 16th, 2022
Lankenau Institute For Medical Research hired George Prendergast as president and CEO on Jan 1st 04'.

When George Prendergast was appointed president and CEO of the Lankenau Institute of Medical Research (LIMR) in 2004, he coined the term “acapreneurial” as a mashup for the model he wanted to implement — inventions and startup incubation alongside traditional academic goals of research, new knowledge and its validation.